KalVista Pharmaceuticals Inc. Intrinsic Value

KALV

KalVista Pharmaceuticals fair value

None of the figures this calculator works from (earnings, free cash flow, revenue, book value, dividends) is positive for KalVista Pharmaceuticals today, so there is nothing to project yet.

SourceFair value computed from the 10-Q filed 7 May 2026, covering the period ending 31 Mar 2026, as reported to the SEC. Data last refreshed 12 Oct 2026. How this is calculated.

Price from market data, last close as of 12 Jun 2026. Fiscal year ends Dec.

Peers

Pharmaceutical Preparations · Pick stocks to compare with KALV

CompareIntrinsic value

XOMAXOMA Corporation

€0.05-3.60%64

OCULOcular Therapeutix Inc.

$7.14+4.69%10

CARMCarisma Therapeutics Inc.

$0.00+100.00%60

SPROSpero Therapeutics Inc.

$1.07+2.88%63

GOSSGossamer Bio Inc.

$9.40+1.29%10

SIGASiga Technologies Inc.

$3.15+1.29%20

QTTBQ32 Bio Inc.

$8.97+2.40%60

TNGXTango Therapeutics Inc.

$23.18+0.04%40

Held by ETFs

KALV is in 3 US ETFs. The largest of them, with KALV's weight in each:

Spot a number that looks wrong? Check it in KALV's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing KALV

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.